Annual report [Section 13 and 15(d), not S-K Item 405]

FINANCIAL INSTRUMENTS

v3.25.0.1
FINANCIAL INSTRUMENTS
12 Months Ended
Dec. 31, 2024
Notes to Financial Statements  
FINANCIAL INSTRUMENTS

NOTE 11 — FINANCIAL INSTRUMENTS

The Company’s financial instruments consist of cash and cash equivalents, restricted cash, accounts receivable, accounts payable, accrued liabilities, derivative instruments and debt. Except for derivative instruments and debt, the carrying amount of the Company’s financial instruments approximates fair value due to the short-term, highly liquid nature of these instruments.

Derivative Instruments

The following table reflects the contracted volumes and weighted average prices under the terms of the Company’s open Henry Hub (NYMEX) natural gas derivative contracts as of December 31, 2024:

Average

Daily

Total

Weighted

Weighted

Weighted

Instrument

Volumes

    

Volumes

    

Strike Price

    

Put Price

    

Call Price

Period

    

Type

    

(Mmbtu)

(Mmbtu)

($/Mmbtu)

($/Mmbtu)

($/Mmbtu)

Jan 2025 - Mar 2025

calls

62,000

5,580,000

$

$

$

5.50

Jan 2025 - Mar 2025

swaps

63,333

5,700,000

$

2.72

$

$

Apr 2025 - Dec 2025

puts

62,182

17,100,000

$

$

2.27

$

Jan 2026 - Dec 2026

puts

55,890

20,400,000

$

$

2.35

$

Jan 2027 - Dec 2027

puts

52,603

19,200,000

$

$

2.37

$

Jan 2028 - Apr 2028

puts

49,587

6,000,000

$

$

2.50

$

The fair value of the Company’s derivative financial instruments was recorded in the Consolidated Balance Sheets as follows (in thousands):

    

December 31, 

2024

2023

Prepaid expenses and other current assets

$

868

$

1,180

Other assets

 

4,150

 

10,068

Accrued liabilities

 

3,731

 

6,267

Other liabilities

2,756

The Company measures the fair value of its derivative instruments on a recurring basis by applying the income approach, using models with inputs that are classified within Level 2 of the valuation hierarchy. The income approach converts expected future cash flows to a present value amount based on market expectations. The inputs used for the fair value measurement of derivative financial instruments are the exercise price, the expiration date, the settlement date, notional quantities, the implied volatility, the discount curve with spreads and published commodity future prices.

The impact of commodity derivative contracts on the Consolidated Statements of Operations was as follows (in thousands):

Year Ended December 31, 

    

2024

    

2023

    

2022

Realized (gain) loss

$

(2,879)

$

4,087

$

125,089

Unrealized gain

(710)

(58,846)

(39,556)

Derivative (gain) loss, net

$

(3,589)

$

(54,759)

$

85,533

Debt

The following table presents the net values and estimated fair values of the Company’s debt (in thousands):

    

December 31, 2024

    

December 31, 2023

Net Value

    

Fair Value

    

Net Value

    

Fair Value

Term Loan

$

112,132

$

109,727

$

111,107

$

108,467

11.75% Notes

272,081

 

278,765

 

269,910

 

283,443

TVPX Loan

9,010

9,395

9,587

10,156

Total

$

393,223

$

397,887

$

390,604

$

402,066

The fair value of the TVPX Loan and the Term Loan were measured using a discounted cash flows model and current market rates. The fair value of the 11.75% Notes was measured using quoted prices, although the market is inactive. The fair value of debt was classified as Level 2 within the valuation hierarchy.